Kopran Ltd
KOPRANKopran Ltd
KOPRAN
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.01 | 3.02 | 0.98% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 298.71 | 320.50 | 322.92 | 360.96 | 360.13 | 509.80 | 488.12 | 554.06 | 629.20 | 651.88 | ||||||||||
Raw Materials | 181.44 | 180.85 | 193.05 | 217.24 | 232.83 | 286.27 | 300.57 | 345.95 | 400.88 | 550.76 | ||||||||||
| Power & Fuel Cost | 14.10 | 13.71 | 14.90 | 17.10 | 18.08 | 16.65 | 19.27 | 23.16 | 24.52 | |||||||||||
| Employee Cost | 28.02 | 31.37 | 32.24 | 37.11 | 36.85 | 37.16 | 43.27 | 49.95 | 52.28 | |||||||||||
| Selling & Administrative Expenses | 25.03 | 25.39 | 28.17 | 27.88 | 29.60 | 34.24 | 35.75 | 35.37 | 37.00 | |||||||||||
| Operating & Other expenses | 18.71 | 22.39 | 14.56 | 12.24 | -4.00 | 35.71 | -8.73 | 44.77 | 25.50 | |||||||||||
EBITDA | 31.41 | 46.79 | 40.00 | 49.39 | 46.77 | 99.77 | 97.99 | 54.86 | 89.02 | 101.12 | ||||||||||
| Depreciation/Amortization | 8.12 | 8.33 | 8.51 | 8.74 | 9.58 | 10.19 | 11.10 | 12.71 | 12.89 | 13.50 | ||||||||||
| PBIT | 23.29 | 38.46 | 31.49 | 40.65 | 37.19 | 89.58 | 86.89 | 42.15 | 76.13 | 87.62 | ||||||||||
| Interest & Other Items | 12.56 | 13.70 | 8.60 | 8.99 | 8.91 | 6.24 | 5.12 | 6.08 | 8.59 | 8.95 | ||||||||||
| PBT | 10.73 | 24.76 | 22.89 | 31.66 | 28.28 | 83.34 | 81.77 | 36.07 | 67.54 | 78.67 | ||||||||||
| Taxes & Other Items | 0.00 | 4.85 | 2.40 | 7.64 | 7.27 | 21.73 | 20.75 | 8.83 | 16.59 | 19.39 | ||||||||||
| Net Income | 10.73 | 19.91 | 20.49 | 24.02 | 21.01 | 61.61 | 61.02 | 27.24 | 50.95 | 59.28 | ||||||||||
| EPS | 2.54 | 4.60 | 4.74 | 5.55 | 4.86 | 14.24 | 13.34 | 5.65 | 10.57 | 12.30 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 | 0.22 | 0.53 | 0.28 | 0.24 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Kopran Ltd | 29.10 | 3.02 | 0.98% |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare KOPRAN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.21%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Kopran Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Bandhan BSE Healthcare Index Fund Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0008% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 85/102 (0) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 2, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Sep 2, 2024
Cash Dividend
Ex DateEx DateSep 7, 2023
Dividend/Share
₹3.00
Ex DateEx Date
Sep 7, 2023
Cash Dividend
Ex DateEx DateAug 4, 2022
Dividend/Share
₹3.00
Ex DateEx Date
Aug 4, 2022
Cash Dividend
Ex DateEx DateAug 5, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Aug 5, 2021
Cash Dividend
Ex DateEx DateNov 5, 2020
Dividend/Share
₹1.50
Ex DateEx Date
Nov 5, 2020
Kopran will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Kopran announced that the Annual General Meeting (AGM) of the company will be held on 11 September 2024.Powered by Capital Market - Live
Net profit of Kopran rose 300.72% to Rs 11.10 crore in the quarter ended June 2024 as against Rs 2.77 crore during the previous quarter ended June 2023. Sales rose 19.18% to Rs 139.44 crore in the quarter ended June 2024 as against Rs 117.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales139.44117.00 19 OPM %13.025.39 - PBDT18.616.87 171 PBT14.733.61 308 NP11.102.77 301 Powered by Capital Market - Live
Kopran has received Environmental Clearance from Government of India ' Ministry of Environment, Forest and Climate Change on 30 July 2024 for manufacturing of synthetic organic chemicals (Active Pharmaceutical Ingredients and its Intermediates) up to 97 MTs/Month at its Manufacturing Unit at Plot no. 663, GIDC Panoli, Taluka: Ankleshwar, District: Bharuch, Gujarat. The Company will now obtain Consent to Establish (CTE) and Consent to Operate (CCA) from Gujarat Pollution Control Board for additional capacities approval under the Environmental Clearance received.Powered by Capital Market - Live
Kopran will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live
Stock market update: Stocks that hit 52-week highs on NSE in today’s trade
Creative Eye Ltd leads gainers in ‘B’ group
SVP Global Textiles Ltd leads losers in ‘B’ group
Chemcon Speciality Chemicals Ltd leads losers in ‘B’ group
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 11.75%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.16% to 0.17%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 16.23%, vs industry avg of 15.28%